SYN120 a Dual 5-HT6/5-HT2A Antagonist Proof of Concept Study to Evaluate its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE)

Administered By

Awarded By

Contributors

Start/End

  • September 1, 2016 - January 18, 2018